Pine Bridge Investments, L.P. Incyte Corp Transaction History

Pine Bridge Investments, L.P.

$13.1 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$56.55 - $66.59 $322,108 - $379,296	-5,696 Reduced 11.7%	42,972 $2.45 Million
Q4 2023 Feb 13, 2024	SELL	$52.16 - $64.19 $740,098 - $910,791	-14,189 Reduced 22.57%	48,668 $3.06 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $3.62 Million - $4.13 Million	62,603 Added 24646.85%	62,857 $3.63 Million
Q2 2023 Aug 11, 2023	SELL	$60.95 - $75.51 $6.36 Million - $7.88 Million	-104,412 Reduced 99.76%	254 $15,000
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $1.13 Million - $1.38 Million	16,066 Added 18.13%	104,666 $7.56 Million
Q4 2022 Feb 09, 2023	BUY	$67.18 - $84.11 $1.2 Million - $1.5 Million	17,804 Added 25.15%	88,600 $7.12 Million
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $4.69 Million - $5.87 Million	70,796 New	70,796 $4.72 Million
Q3 2020 Nov 13, 2020	SELL	$85.07 - $109.69 $76,137 - $98,172	-895 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$74.18 - $108.93 $9.86 Million - $14.5 Million	-132,940 Reduced 99.33%	895 $93,000
Q1 2020 May 14, 2020	BUY	$63.18 - $85.97 $8.46 Million - $11.5 Million	133,835 New	133,835 $9.8 Million
Q4 2018 Feb 13, 2019	SELL	$58.5 - $69.94 $1.34 Million - $1.6 Million	-22,867 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$61.75 - $74.23 $109,174 - $131,238	-1,768 Reduced 7.18%	22,867 $1.58 Million
Q1 2018 May 14, 2018	SELL	$83.06 - $100.98 $67,444 - $81,995	-812 Reduced 3.19%	24,635 $2.05 Million
Q4 2017 Feb 09, 2018	SELL	$93.56 - $116.6 $4.52 Million - $5.63 Million	-48,307 Reduced 65.5%	25,447 $2.41 Million
Q3 2017 Nov 13, 2017	SELL	$109.15 - $138.27 $91,249 - $115,593	-836 Reduced 1.12%	73,754 $8.61 Million
Q2 2017 Aug 11, 2017	BUY	N/A	74,590	74,590 $9.39 Million

Others Institutions Holding INCY

# of Institutions

642

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.

Account